Depression and adherence to medical advice

Depression and Physical Illness

Volumn , Issue , 2006, Pages 369-396

  Raynor, Douglas A ^a   Wing, Rena R ^a   Phelan, Suzanne ^b  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77950286293     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544293.018     Document Type: Chapter

References (82)

1. W. Katon, Depression: Relationship to somatization and chronic medical illness. J. Clin. Psychol.45(1984), 4–11.
2. K. B. Wells, W. Rogers, M. A. Burnam, S. Greenfield, J. E. Ware, Jr, Howthe medical comorbidity of depressed patients differs across health care settings: results fromtheMedical Outcomes Study. Am. J. Psychiatry148(1991), 1688–96.
3. M. R. DiMatteo, H. D. Lepper, T. W. Croghan, Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch. Intern. Med.160(2000), 2101–107.
4. R. B. Haynes, D. W. Taylor, D. L. Sackett, Compliance in Health Care(Baltimore, MD: Johns Hopkins University Press, 1979).
5. R. M. Kaplan, H. J. Simon, Compliance in medical care: reconsideration of self-predictions. Ann. Behav. Med.12(1990), 66–71.
6. J. M. Dunbar-Jacob, S. Sereika, J. Rohay, L. E. Burke, Electronic methods in assessing adherence to medical regimens. In Technology andMethods in BehavioralMedicine, ed. D. S. Krantz, A. Baum (Mahwah, NJ: Lawrence Erlbaum Associates, 1998), pp. 95–113.
7. J. M. Dunbar-Jacob, E. A. Schlenk, L. E. Burke, J. T. Matthews, Predictors of patient adherence: patient characteristics. In The Handbook of Health Behavior Change, 2nd edn, ed. S. A. Shumaker, E. B. Schron, J. K. Ockene, W. L. McBee (New York: Springer, 1998), pp. 491–511.
8. J. A. Trostle, The idealogy of adherence: an anthropological and historical perspective. In Promoting Adherence to Medical Treatment in Chronic Childhood Illness: Concepts, Methods, and Interventions, ed. D. Drotar (Mahwah, NJ: Lawrence Erlbaum Associates, 2000), pp. 37–55.
9. L. B. Myers, K. Midence, Concepts and issues in adherence. In Adherence to Treatement in Medical Conditions, ed. K. Midence (Amsterdam: Harwood Academics, 1998), pp. 1–24.
10. J. M. Dunbar-Jacob, L. E. Burke, S. Puczynski, Clinical assessment and management of adherence to medical regimens. In Managing Chronic Illness: A Biopsychosocial Perspective, ed. P. M. Nicassio, T. W. Smith (Washington, DC: American PsychologicalAssociation, 1995), pp. 313–49.
11. M. N. Gourevitch, W. Wasserman, M. S. Panero, P. A. Selwyn, Successful adherence to observed prophylaxis and treatment of tuberculosis among drug-users in a methadone program. J. Addict. Dis.15(1996), 93–104.
12. J. W. Mellors, Clinical implications of resistance and cross-resistance to HIV protease inhibitors. Infect. Med. Suppl (1997), 32–8.
13. A. L. Plough, Social and contextual factors in the analyses of mortality in end-stage renal disease: implications for health policy. Am. J. Public Health72(1992), 1293–5.
14. M. R. DiMatteo, Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med. Care42(2004), 200–209.
15. L. J. Bauman, A patient-centered approach to adherence: risks for nonadherence. In Promoting Adherence to Medical Treatment in Chronic Childhood Illness: Concepts, Methods and Interventions, ed. D. Drotar (Mahwah, NJ: Lawrence Erlbaum Associates, 2000).
16. L. Warren, P. Hixenbaugh, Adherence and diabetes. In Adherence to Treatment in Medical Conditions, ed. L. B. Myers, K. Midence (Amsterdam: Harwood Academic, 1998), pp. 423–54.
17. J. Jakicic, R. R. Wing, C. Winters-Hart, Relationship of physical activity to eating behaviors and weight loss in women. Med. Sci. Sports Exer.34(2002), 1653–9.
18. L. C. Schafer, R. E. Glasgow, K. D. McCaul, M. Dreher, Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabet. Care6(1893), 493–8.
19. R. J. Hill, P. S. Davies, The validity of self-reported energy intake as determined using the doubly labeled water technique. Br. J. Nutr.85(2001), 415–30.
20. M. Z. Vitolins, C. S. Rand, S. R. Rapp, P. M. Ribisl, M. Sevick, Measuring adherence to behavioral and medical interventions. Control. Clin. Trials21: Suppl 1 (2000), 188–94.
21. D. J. Ossip-Klein, G. Bigelow, S. R. Parker, S. Curry, Task force 1: classification and assessment of smoking behavior. Health Psychol.5. Suppl (1986), 3–11.
22. J. C. Coyne, Self-reported distress: analog or ersatz depression? Psychol. Bull.116(1994), 29–45.
23. American Psychiatric Association, Diagnostic and StatisticalManual ofMental Disorders, 4th edn (Washington, DC: American Psychiatric Association, 1994).
24. W. Coryell, H. S. Akiskal, A. C. Leon, et al., The time course of nonchronic major depressive disorder: uniformity across episodes and samples. Arch. Gen. Psychiatry51(1994), 405–10.
25. A. T. Beck, C. H. Ward, M. Mendelson, J. Mock, J. Erbaugh, An inventory for measuring depression. Arch. Gen. Psychiatry4(1961), 53–63.
26. L. S. Radloff, The CES-D scale: a self-report depression scale for research in the general population. Appl. Psychol. Meas.1(1977), 385–401.
27. J. Rodin, J. Mancuso, J. Granger, E. Nelbach, Food cravings in relation to body mass index, restraint and estradiol levels: a repeated measures study in healthywomen. Appetite17(1991), 177–85.
28. G. L. Flett, K. Vredenburg, L. Krames, The continuity of depression in clinical and nonclinical samples. Psychol. Bull.121(1997), 395–416.
29. R. L. Spitzer, J. Endicott, E. Robins, Research diagnostic criteria: Rationale and reliability. Arch. Gen. Psychiatry35(1978), 773–82.
30. L. N. Robins, J. E. Helzer, J. Croughan, K. S. Ratcliff, National institute of mental health diagnostic interview schedule. Arch. Gen. Psychiatry38(1981), 381–9.
31. M. B. First, R. L. Spitzer, M. Gibbon, J. B. W. Williams, Structured Clincal Interview for DSM-IV Axis I Disorders. Washington, DC: American Psychiatric Association, 1996.
32. G. Rodin, J. Craven, C. Littlefield, Depression in the Medically Ill: An Integrated Approach(New York: Brunner/Mazel, 1991).
33. K. A. Yonkers, J. Samson, Mood DisordersMeasures(Washington, DC: American Psychiatric Association, 2000).
34. L. Smithline, Is depression a risk factor for cardiovascular disease? A critical review. Examination paper. Pittsburgh, PA: University of Pittsburgh, 1997.
35. D. G. Blazer, R. C. Kessler, K. A. McGonagle, M. S. Swartz, The prevalence and distribution of major depression in a national comorbidity survey. Am. J. Psychiatry151(1994), 979–86.
36. P. A. Ades, M. L. Waldmann, W. J. McCann, S. O. Weaver, Predictors of cardiac rehabilitation participation in older coronary patients. Arch. Intern. Med.152(1992), 1033–5.
37. S. K. Avants, A. Margolin, L. A. Warburton, K. A. Hawkins, J. Shi, Predictors of nonadherence to HIV-related medication regimens during methadone stabilization. Am. J. Addict.10(2001), 69–78.
38. A. Ayres, P. W. Hoon, J. B. Franzoni, et al., Influence of mood and adjustment to cancer on compliance with chemotherapy among breast cancer patients. J. Psychosom. Res.38(1994), 393–402.
39. J. A. Blumenthal, S. Williams, A. G. Wallace, R. B. Williams, T. L. Needles, Physiological and psychological variables predict compliance to prescribed exercise therapy in patients recovering from myocardial infarction. Psychosom. Med.44(1982), 519–27.
40. C. M. Bosley, J. A. Fosbury, G. M. Cochrane, The psychological factors associated with poor compliance with treatment in asthma. Eur. Respir. J.8(1995), 899–904.
41. C. M. Bosley, Z. M. Corden, P. J. Rees, G. M. Cochrane, Psychological factors associated with use of home nebulized therapy for COPD. Eur. Respir. J.9(1996), 2346–50.
42. R. J. Botelho, R. Dudrak, Home assessment of adherence to long-term medication in the elderly. J. Fam. Pract.35(1992), 61–5.
43. R. M. Carney, K. E. Freedland, S. A. Eisen, M. W. Rich, A. S. Jaffe, Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol. 14(1995), 88–90.
44. R. M. Carney, K. E. Freedland, S. A. Eisen, et al., Adherence to prophylactic medication regimen in patients with symptomatic versus asymptomatic ischemic heart disease. Behav. Med.24(1998), 35–9.
45. M. P. Carrieri, M. A. Chesney, B. Spire, et al., Failure to maintain adherence to HAART in a cohort of French HIV-positive injecting drug users. Int. J. Behav. Med.10(2003), 1–14.
46. S. L. Catz, J. A. Kelly, L. M. Bogart, E. G. Benotsch, T. L. McAuliffe, Patterns, correlates, and barriers to medication adherence among persons prescribed new treatments for HIV disease. Health Psychol. 19(2000), 124–33.
47. P. S. Ciechanowski, W. J. Katon, J. O. Russo, Depression and diabetes: Impact of depressive symptoms on adherence, function, and costs. Arch. Intern. Med.160(2000), 3278–85.
48. P. S. Ciechanowski, W. J. Katon, J. E. Russo, I. B. Hirsch, The relationship of depressive symptoms to symptom reporting, self-care and glucose control in diabetes. Gen. Hosp. Psychiatry25(2003), 246–52.
49. S. Cluley, G. M. Cochrane, Psychological disorder in asthma is associated with poor control and poor adherence to inhaled steriods. Respir. Med.95(2001), 37–9.
50. A. K. De-Nour, J. W. Czaczkes, The influence of patient’s personality on adjustment to chronic dialysis. J. Nerv. Ment. Dis.162(1976), 323–33.
51. W. W. Eaton, D. E. Larson, M. Mengel, R. Campbell, R. B. Montague, Psychosocial and psychologic influences on management and control of insulin-dependent diabetes. Int. J. Psychiatr. Med.22(1992), 105–17.
52. K. D. Everett, P. J. Brantley, C. Sletten, G. N. Jones, G. T. McKnight, The relation of stress and depression to interdialytic weight gain in hemodialysis patients. Behav. Med.21(1995), 25–30.
53. P. Frazier, K. Davis-Ali, K. E. Dahl, Correlates of noncompliance among renal transplant recipients. Clin. Transpl.8(1994), 550–57.
54. O. Gilbar, A. K. De-Nour, Adjustment to illness and dropout of chemotherapy. J. Psychosom. Res.33(1989), 1–5.
55. K. M. Glazer, C. F. Emery, D. J. Frid, R. E. Banyasz, Psychological predictors of adherence and outcomes among patients in cardiac rehabilitation. J. Cardiopulm. Rehabil.22(2002), 40–46.
56. V. Gordillo, J. delAmo, V. Soriano, J. Gonzalez-Lahoz, Sociodemographic and psychological variables influencing adherence to antiretroviral therapy. AIDS13(1999), 1763–9.
57. E. A. Graveley, C. S. Oseasohn, Multiple drug regimens: medication compliance among veterans 65 years and older. Res. Nurs. Health14(1991), 51–8.
58. E. Guiry, R. M. Controy, N. Hickey, R. Mulcahy, Psychological response to an acute coronary event and its effect on subsequent rehabilitation and lifestyle change. Clin. Cardiol.10(1987), 256–60.
59. R. C. Katz, J. Ashmore, E. Barboa, et al.Knowledge of disease and dietary compliance in patients with end-stage renal disease. Psychol. Rep.82(1998), 331–6.
60. D. J. Kiley, C. S. Lam, R. Pollak, A study of treatment compliance following kidney transplantation. Transplantation55(1993), 51–6.
61. P. L. Kimmel, R. A. Peterson, K. L. Weihs, et al., Psychosocial factors, behavioral compliance and survival in urban hemodialysis patients. Kidney Int. 54(1998), 245–54.
62. A. H. Lebovits, J. J. Strain, S. J. Schleifer, et al., Patient noncompliance with self-administered chemotherapy. Cancer65(1990), 17–22.
63. E. M. McDonough, J. H. Boyd, M. A. Vavares, M. D. Maves, Relationship between psychological status and compliance in a sample of patients treated for cancer of the head and neck. Head Neck18(1996), 269–76.
64. D. C. Mohr, D. E. Goodking, W. Likosky, et al., Treatment of depression improves adherence to interferon beta-1b therapy for multiple sclerosis. Arch. Neurol.54(1997), 531–3.
65. D. L. Paterson, S. Swindells, J. Mohr, et al., Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann. Intern. Med.133(2000), 21–30.
66. A. Rodriguez, M. Diaz, A. Colon, E. A. Santiago-Delpin, Psychosocial profile of noncompliant transplant patients. Transplant. Proc.23(1991), 1807–809.
67. M. S. Schneider, R. Friend, P. Whitaker, N. K. Wadhwa, Fluid noncompliance and symptomatology in end-stage renal disease: Cognitive and emotional variables. Health Psychol. 10(1991), 209–15.
68. N. Singh, C. Squier, C. Sivek, et al., Determinants of compliance with antiretroviral therapy in patients with human immunodeficiency virus: prospective assessment with implications for enhancing compliance. AIDS Care8(1996), 261–9.
69. B. Spire, S. Duran, M. Souville, et al., Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach. Soc. Sci. Med.54(2002), 1481–96.
70. E. Taal, J. J. Rasker, E. R. Seydel, O. Wiegman, Health status, adherence with health recommendations, self-efficacy and social support in patients with rheumatoid arthritis. Patient Educ. Couns.20(1993), 63–76.
71. J. S. Tucker, A. Burnam, C. D. Sherbourne, F. Y. Kung, A. L. Gifford, Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection. Am. J. Med.114(2003), 573–80.
72. B. J. Turner, C. Laine, L. Cosler, W. W. Hauck, Relationship of gender, depression, and health care delivery with antiretroviral adherence in HIV-infected drug users. J. Gen. Intern. Med.18(2003), 248–57.
73. P. S. Wang, R. L. Bohn, E. Knight, et al., Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J. Gen. Intern. Med.17(2002), 504–11.
74. A. Williams, R. Stephens, T. McKnight, S. Dodd, Factors affecting adherence of end-stage renal disease patients to an exercise programme. Br. J. Sports Med.25(1991), 90–3.
75. W. Wilson, V. Ary, A. Biglan, et al., Psychosocial predictors of self-care behaviors (compliance) and glycemic control in non-insulin-dependent diabetes mellitus. Diabetes Care9(1986), 614–22.
76. R. C. Ziegelstein, J. A. Fauerbach, S. S. Stevens, et al., Patients with depression are less likely to followrecommendations to reduce cardiac risk during recovery fromamyocardial infarction. Arch. Intern. Med.160(2000), 1818–23.
77. P. J. Goodnick, A. Kumar, J. H. Henry, V. M. V. Buki, R. B. Goldberg, Sertraline in coexisting major depression and diabetes mellitus. Psychopharmacol. Bull.33(1997), 261–4.
78. P. J. Lustman, L. S. Griffith, R. E. Clouse, et al., Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom. Med.59(1997), 241–50.
79. P. J. Lustman, L. S. Griffith, K. E. Freedland, S. S. Kissel, R. E. Clouse, Cognitive behavior therapy for depression in type 2 diabetes mellitus: a randomized, controlled trial. Ann. Intern. Med.129(1998), 613–21.
80. J. W. Williams, W. Katon, E. Lin, et al., The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann. Intern. Med.140(2004), 1015–24.
81. R. M. Baron, D. A. Kenny, The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J. Pers. Soc. Psychol.51(1986), 1173–82.
82. R. R. Wing, S. Phelan, D. F. Tate, The role of adherence in mediating the relationship between depression and health outcomes. J. Psychosom. Res.53(2002), 877–81.